BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
DRD2
,
glucose metabolic process
,
Lung cancer
,
Stem cell
,
Biofuel
,
Quercetin
,
rs2300478
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
tlr9 protein
Summary
General Info
Curated Studies
Most Correlated Studies
Plasmacytoid dendritic cells treated with TLR7 and TLR9 agonists in the presence or absence of RN486
Whole blood of IRAK4-null, MYD88-null and normal donors treated with Toll-like receptor agonists
Macrophage and Monocytes Stimulated By Flagellin
MLE-15 mouse respiratory epithelial cell line treated with TLR ligands ODN2395 and Pam2CSK4
Respiratory epithelial cells treated with synthetic TLR ligands ODN2395 and/or Pam2CSK4
Explore Curated Studies Results
Literature
Most Relevant Literature
Spatially Controlled Activation of Toll-like Receptor 9 with DNA-Based Nanomaterials.
Tubular expression of Toll-like receptor 9 in lupus and primary membranous nephropathy.
Toll-like receptor 9 (-1237 T/C, -1486 T/C) and the risk of gastric cancer: a meta-analysis of genet…
MTMR3 risk alleles enhance Toll Like Receptor 9-induced IgA immunity in IgA nephropathy.
RETRACTED ARTICLE: Curcumin deactivates M2 macrophages to alleviate lung fibrosis in IgG4-related di…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Feasibility of Autologous Tumor Cell-TLR9 Agonist Vaccination for Metastatic Colorectal Cancer
Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination With Nivolumab vs. Nivolumab
Phase II Trial to Evaluate an EBV-derived Dendritic Cell Vaccine in Autologous Stem Cell Transplant
Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resis…
A Phase I/II Study of Intratumoral Injection of SD-101
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ